Color Health started in 2013 as Color Genomics, offering affordable genetic testing for hereditary cancer risk. The company made clinical-grade BRCA testing available for a fraction of the usual cost, opening up genetic screening to people who wouldn’t normally have access through traditional healthcare channels.
During the COVID-19 pandemic, Color pivoted hard into public health infrastructure. The company ran testing and vaccination programs for cities, states, and large employers across the US. At peak, Color was processing millions of COVID tests and managing vaccination appointments for major jurisdictions including San Francisco and Los Angeles County. This experience in large-scale health program management became a core part of the business.
More recently, Color has focused on cancer screening programs powered by AI. The company works with employers and health systems to identify high-risk individuals and guide them through appropriate screening pathways. Color’s platform handles everything from risk assessment and genetic testing to care navigation and follow-up. The company has raised over $270 million and positions itself as a population health platform rather than just a genetic testing lab.
